Table 1.

Study Participant Characteristics at Baseline (n = 301)

No. (%)
Age, median (IQR), y40 (33–47)
Gender
 Female154 (51.2)
 Male147 (48.8)
More than a primary education
 No220 (73.1)
 Yes81 (26.9)
Married
 No100 (33.3)
 Yes200 (66.7)
Literacy (able to read full sentences)
 No83 (27.6)
 Yes218 (72.4)
AST value, median (IQR)32 (25–40)
ALT value, median (IQR)28 (22–38)
Self-reported ART adherence, prior 30 d
 Excellent164 (54.5)
 Very good81 (26.9)
 Good51 (16.9)
 Fair3 (1.0)
 Poor1 (0.3)
 Very poor1 (0.3)
Social Desirability Score, median (IQR)20 (18–22)
Self-reported alcohol use (any in the prior 3 mo)
 No100 (33)
 Yes201 (67)
Alcohol use (combination of self-report, Audit-C, and PEth)
 Abstainer86 (28.6)
 Any, not unhealthy66 (21.9)
 Unhealthy149 (49.5)
Time since HIV diagnosis, median (IQR), y7.16 (5.05–11.40)
Undetectable viral load
 No23 (7.9)
 Yes269 (92)
No. (%)
Age, median (IQR), y40 (33–47)
Gender
 Female154 (51.2)
 Male147 (48.8)
More than a primary education
 No220 (73.1)
 Yes81 (26.9)
Married
 No100 (33.3)
 Yes200 (66.7)
Literacy (able to read full sentences)
 No83 (27.6)
 Yes218 (72.4)
AST value, median (IQR)32 (25–40)
ALT value, median (IQR)28 (22–38)
Self-reported ART adherence, prior 30 d
 Excellent164 (54.5)
 Very good81 (26.9)
 Good51 (16.9)
 Fair3 (1.0)
 Poor1 (0.3)
 Very poor1 (0.3)
Social Desirability Score, median (IQR)20 (18–22)
Self-reported alcohol use (any in the prior 3 mo)
 No100 (33)
 Yes201 (67)
Alcohol use (combination of self-report, Audit-C, and PEth)
 Abstainer86 (28.6)
 Any, not unhealthy66 (21.9)
 Unhealthy149 (49.5)
Time since HIV diagnosis, median (IQR), y7.16 (5.05–11.40)
Undetectable viral load
 No23 (7.9)
 Yes269 (92)

Abbreviations: ALT, alanine transaminase; ART, antiretroviral therapy; AST, aspartate transaminase; IQR, interquartile range.

Table 1.

Study Participant Characteristics at Baseline (n = 301)

No. (%)
Age, median (IQR), y40 (33–47)
Gender
 Female154 (51.2)
 Male147 (48.8)
More than a primary education
 No220 (73.1)
 Yes81 (26.9)
Married
 No100 (33.3)
 Yes200 (66.7)
Literacy (able to read full sentences)
 No83 (27.6)
 Yes218 (72.4)
AST value, median (IQR)32 (25–40)
ALT value, median (IQR)28 (22–38)
Self-reported ART adherence, prior 30 d
 Excellent164 (54.5)
 Very good81 (26.9)
 Good51 (16.9)
 Fair3 (1.0)
 Poor1 (0.3)
 Very poor1 (0.3)
Social Desirability Score, median (IQR)20 (18–22)
Self-reported alcohol use (any in the prior 3 mo)
 No100 (33)
 Yes201 (67)
Alcohol use (combination of self-report, Audit-C, and PEth)
 Abstainer86 (28.6)
 Any, not unhealthy66 (21.9)
 Unhealthy149 (49.5)
Time since HIV diagnosis, median (IQR), y7.16 (5.05–11.40)
Undetectable viral load
 No23 (7.9)
 Yes269 (92)
No. (%)
Age, median (IQR), y40 (33–47)
Gender
 Female154 (51.2)
 Male147 (48.8)
More than a primary education
 No220 (73.1)
 Yes81 (26.9)
Married
 No100 (33.3)
 Yes200 (66.7)
Literacy (able to read full sentences)
 No83 (27.6)
 Yes218 (72.4)
AST value, median (IQR)32 (25–40)
ALT value, median (IQR)28 (22–38)
Self-reported ART adherence, prior 30 d
 Excellent164 (54.5)
 Very good81 (26.9)
 Good51 (16.9)
 Fair3 (1.0)
 Poor1 (0.3)
 Very poor1 (0.3)
Social Desirability Score, median (IQR)20 (18–22)
Self-reported alcohol use (any in the prior 3 mo)
 No100 (33)
 Yes201 (67)
Alcohol use (combination of self-report, Audit-C, and PEth)
 Abstainer86 (28.6)
 Any, not unhealthy66 (21.9)
 Unhealthy149 (49.5)
Time since HIV diagnosis, median (IQR), y7.16 (5.05–11.40)
Undetectable viral load
 No23 (7.9)
 Yes269 (92)

Abbreviations: ALT, alanine transaminase; ART, antiretroviral therapy; AST, aspartate transaminase; IQR, interquartile range.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close